首页> 外国专利> Composite polymeric material for biological and medical applications and the method for its preparation

Composite polymeric material for biological and medical applications and the method for its preparation

机译:用于生物和医学用途的复合聚合物材料及其制备方法

摘要

The invention relates to a composite polymeric material suitable for biological and medical applications and to the method for preparation thereof. The composite material consists of 1-99 wt. % of hydrophilic polymer or copolymer based on methacrylic or acrylic esters, 1-99 wt. % of fibrillar collagen, and up to 2.5 wt. % of a crosslinking agent, based on both polymeric components. The composite material may further comprise biologically active compounds and other auxiliary materials, as fillers and/or plasticizers. The composite material is prepared by dispersing the fibrillar collagen in a solution or a highly swollen dispersion of the synthetic hydrophilic polymer or copolymer in a lyotropic agent and the subsequent removal of the lyotropic agent, thus forming a matrix of the synthetic polymer or copolymer penetrated by fibrillar collagen or vice versa. The composite material may be applied on a solid support or reinforced with glass, plastics, cellulose, or metallic materials. PPA method for the preparation of the composite material consists in dispersing of fibrillar collagen in a solution or a highly swollen dispersion of the synthetic hydrophilic polymer or copolymer in a lyotropic agent, e.g. in water diluted carboxylic acids, strongly acidified aqueous mixtures of ethanol and methanol, high-concentrated aqueous solutions of lyotropic salts, and high-concentrated aqueous solutions of urea or guanidinium chloride, at temperature not exceeding 37° C., and the subsequent removing of the lyotropic agent from the viscous dispersion at temperature not exceeding 37° C. using the known methods.PPThe crosslinking agent, e.g. trimethylolurea, formaldehyde, acetaldehyde, glutaraldehyde, starch dialdehyde, glyoxal, or Cr(III) salts, may be added in the course of preparation of the dispersion or after removal of the lyotropic agent.
机译:本发明涉及适用于生物和医学应用的复合聚合物材料及其制备方法。复合材料由1-99 wt。 1-99wt。%的基于甲基丙烯酸或丙烯酸酯的亲水性聚合物或共聚物。 %的原纤维胶原蛋白,最高可达2.5 wt。以两种聚合物组分为基准计,以交联剂的百分数计。复合材料可以进一步包含生物活性化合物和其他辅助材料,作为填充剂和/或增塑剂。通过将原纤维胶原分散在合成亲水性聚合物或共聚物在溶致剂中的溶液中或高度溶胀的分散体中,然后除去溶致剂,从而形成合成聚合物或共聚物被渗透的基质来制备复合材料。原纤维胶原蛋白,反之亦然。可以将复合材料施加在固体支持物上或用玻璃,塑料,纤维素或金属材料增强。制备复合材料的方法在于将原纤维胶原分散在溶液中或高度分散的溶液中。合成亲水聚合物或共聚物在溶致剂中的溶胀分散体,例如在不超过37°C的温度下,在水稀释的羧酸,强酸化的乙醇和甲醇的水性混合物,高浓度的溶致盐的水溶液以及高浓度的尿素或胍盐的水溶液中,随后除去使用已知方法在不超过37℃的温度下从粘性分散体得到溶致剂。交联剂,例如在分散体的制备过程中或除去溶致剂后,可以加入三羟甲基脲,甲醛,乙醛,戊二醛,淀粉二醛,乙二醛或Cr(III)盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号